Cargando…

Observational study of antibody levels after second and third SARS‐CoV‐2 vaccinations in medical workers

BACKGROUND: Countries around the world are actively promoting vaccination against COVID‐19. We observed the changes in serum neutralizing antibody titers in medical workers vaccinated with inactivated COVID‐19 vaccine, in order to explore the necessity of a third dose of vaccination. METHODS: A tota...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Qing, Zhou, Wenyan, Jiang, Wencan, Jia, Xingwang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701844/ https://www.ncbi.nlm.nih.gov/pubmed/36250228 http://dx.doi.org/10.1002/jcla.24731

Ejemplares similares

Sars-Cov-2 Antibody Levels in Blood Cancer Patients after a Third Sars-Cov-2 “Booster” Vaccination - Observational Data from the LLS National Registry
por: Greenberger, Lee M, et al.
Publicado: (2021)

Antibody acquisition after second and third SARS-CoV-2 vaccinations in Japanese kidney transplant patients: a prospective study
por: Deguchi, Hidetaka, et al.
Publicado: (2023)

Antibody Response in Healthcare Workers before and after the Third Dose of Anti-SARS-CoV-2 Vaccine: A Pilot Study
por: Panico, Alessandra, et al.
Publicado: (2022)

Durability and determinants of anti-SARS-CoV-2 spike antibodies following the second and third doses of mRNA COVID-19 vaccine
por: Yamamoto, Shohei, et al.
Publicado: (2023)

Effect of the third dose of BNT162b2 COVID-19 mRNA vaccine on anti-SARS-CoV-2 antibody levels in healthcare workers
por: Tanaka, Hidenori, et al.
Publicado: (2023)

Serological findings following the second and third SARS‐CoV‐2 vaccines in lung transplant recipients
por: Bárczi, Enikő, et al.
Publicado: (2022)

Neutralizing antibodies to SARS‐CoV‐2 Omicron variant after third mRNA vaccination in health care workers and elderly subjects
por: Haveri, Anu, et al.
Publicado: (2022)

The effect of the third dose of the BNT162b2 vaccine on anti-SARS-CoV-2 spike antibody levels in healthcare workers with and without COVID-19 infection
por: Wolszczak-Biedrzycka, Blanka, et al.
Publicado: (2023)

IgG level of the third booster dose for mRNA of SARS-CoV-2 vaccines among Iraqi healthcare workers
por: Rasheed, Waleed S., et al.
Publicado: (2023)

Potent antibody immunity to SARS‐CoV‐2 variants elicited by a third dose of inactivated vaccine
por: Ju, Bin, et al.
Publicado: (2022)

Antibody response after a third dose mRNA-1273 vaccine among vaccinated healthcare workers with two doses of inactivated SARS-CoV-2 vaccine
por: Cucunawangsih, Cucunawangsih, et al.
Publicado: (2022)

Is the second dose of vaccination useful in previously SARS-CoV-2-infected healthcare workers?
por: Pean De Ponfilly, G., et al.
Publicado: (2021)

Time of Day of Vaccination Affects SARS-CoV-2 Antibody Responses in an Observational Study of Health Care Workers
por: Wang, Wei, et al.
Publicado: (2021)

Third BNT162b2 Vaccine Booster Dose against SARS-CoV-2-Induced Antibody Response among Healthcare Workers
por: Hussein, Khetam, et al.
Publicado: (2022)

Immunological detection of serum antibodies in pediatric medical workers exposed to varying levels of SARS-CoV-2
por: Tu, Danna, et al.
Publicado: (2021)

Association of a third vaccination with antibody levels and side reactions in essential workers: A prospective cohort study
por: Hamada, Hiroshi, et al.
Publicado: (2023)

Third-Dose BNT162b2 Vaccination Elicits Markedly High-Level SARS-CoV-2–Neutralizing Antibodies in Vaccinees Who Responded Poorly to a Second Dose in Japan
por: Amano, Masayuki, et al.
Publicado: (2022)

Amplitudes and kinetic of antibodies after second and third doses of BNT162b2 vaccine in nonagenarians and centenarians with and without prior SARS-CoV-2 infection
por: Tuaillon, Edouard, et al.
Publicado: (2022)

Kinetics of SARS-CoV-2 Spike Antibodies after the Second and Third Dose of the BNT162b2 COVID-19 Vaccine and Association with Epidemiological Characteristics and Breakthrough Infection in a Cohort Study of Healthcare Workers
por: Tatsi, Elizabeth-Barbara, et al.
Publicado: (2023)

Seroprevalence of SARS-CoV-2 antibodies in vaccinated healthcare workers in Marrakech (Morocco)
por: Ben Houmich, Taoufik, et al.
Publicado: (2022)

Protection with a Third Dose of mRNA Vaccine against SARS-CoV-2 Variants in Frontline Workers
por: Yoon, Sarang K., et al.
Publicado: (2022)

SARS-CoV-2 antibody responses post-vaccination in UK healthcare workers with pre-existing medical conditions: a cohort study
por: Ward, Victoria, et al.
Publicado: (2022)

The effect of a third-dose BNT162b2 vaccine on anti-SARS-CoV-2 antibody levels in immunosuppressed patients
por: Saiag, Esther, et al.
Publicado: (2022)

Antibody response to a third dose of SARS‐CoV‐2 vaccine in heart and lung transplant recipients
por: Alejo, Jennifer L., et al.
Publicado: (2022)

SARS-CoV-2-antibody response in health care workers after vaccination or natural infection in a longitudinal observational study
por: Herzberg, Jonas, et al.
Publicado: (2022)

High Levels of Anti-SARS-CoV-2 Receptor-Binding Domain (RBD) Antibodies One Year Post Booster Vaccinations among Hospital Workers in Indonesia: Was the Second Booster Needed?
por: Muslimah, Amila Hanifan, et al.
Publicado: (2023)

654: A THIRD DOSE OF SARS-COV-2 VACCINE YIELDS HIGH ANTIBODY LEVELS COMPARED TO TWO DOSE VACCINATION SCHEDULE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
por: Quan, Joshua, et al.
Publicado: (2022)

Rapid antibody testing for SARS-CoV-2 vaccine response in pediatric healthcare workers
por: Heyming, Theodore W., et al.
Publicado: (2021)

Antibody response to the inactivated SARS-CoV-2 vaccine among healthcare workers, Indonesia
por: Cucunawangsih, Cucunawangsih, et al.
Publicado: (2021)

Antibodies to NCP, RBD and S2 SARS-CoV-2 in Vaccinated and Unvaccinated Healthcare Workers
por: Błaszczuk, Agata, et al.
Publicado: (2022)

SARS-CoV-2 Antibody Dynamics in Healthcare Workers after mRNA Vaccination
por: Dieckhaus, Kevin D., et al.
Publicado: (2023)

Decline of Anti-SARS-CoV-2 IgG Antibody Levels 6 Months after Complete BNT162b2 Vaccination in Healthcare Workers to Levels Observed Following the First Vaccine Dose
por: Đaković Rode, Oktavija, et al.
Publicado: (2022)

The Levels of Anti-SARS-CoV-2 Spike Protein IgG Antibodies Before and After the Third Dose of Vaccination Against COVID-19
por: Łysek-Gładysińska, Małgorzata, et al.
Publicado: (2023)

A third dose of inactivated SARS-CoV-2 vaccine induces robust antibody responses in people with inadequate response to two-dose vaccination
por: Zhou, Taicheng, et al.
Publicado: (2022)

Antibody response following the third and fourth SARS-CoV-2 vaccine dose in individuals with common variable immunodeficiency
por: Nielsen, Bibi Uhre, et al.
Publicado: (2022)

Antibody Titers After a Third and Fourth SARS-CoV-2 Vaccine Dose in Bizen City, Japan
por: Kadowaki, Tomoka, et al.
Publicado: (2023)

Antibody induction and immune response in nasal cavity by third dose of SARS-CoV-2 mRNA vaccination
por: Ishizaka, Aya, et al.
Publicado: (2023)

Positivity of SARS-CoV-2 Antibodies among Korean Healthy Healthcare Workers 1 and 2 Weeks after Second Dose of Pfizer-BioNTech Vaccination
por: Kim, Namhee, et al.
Publicado: (2021)

Third trimester messenger RNA COVID-19 booster vaccination upsurge maternal and neonatal SARS-CoV-2 immunoglobulin G antibody levels at birth
por: Kugelman, Nir, et al.
Publicado: (2022)

Seroconversion following the first, second, and third dose of SARS-CoV-2 vaccines in immunocompromised population: a systematic review and meta-analysis
por: Mehrabi Nejad, Mohammad-Mehdi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tpphmo1cbg0ncgufnam8i7p0il